Standardization of coding definitions for sickle cell disease complications: A systematic literature review

被引:0
|
作者
Ericksen, Paulette Negron [1 ]
Dabbous, Firas [2 ]
Ghosh, Rajrupa [2 ]
Shah, Surbhi [2 ]
Sun, Xunming [1 ]
Meier, Emily Riehm [1 ]
Colavecchia, Carmine [1 ]
机构
[1] Pfizer Inc, New York, NY 10001 USA
[2] Evidera, Data Analyt Real World Evidence, Bethesda, MD USA
关键词
comorbidities; complications; diagnosis codes; real-world evidence; sickle cell disease; systematic literature review; ACUTE CHEST SYNDROME; RISK-FACTORS; CLINICAL-OUTCOMES; UNITED-STATES; MORTALITY; ASSOCIATION; US; PREVALENCE; MANAGEMENT; CHILDREN;
D O I
10.1002/pds.5769
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PurposeSickle cell disease (SCD) affects all organ systems and is characterized by numerous acute and chronic complications and comorbidities. Standardized codes are needed for complications/comorbidities used in real-world evidence (RWE) studies that rely on administrative and medical coding. This systematic literature review was conducted to produce a comprehensive list of complications/comorbidities associated with SCD, along with their diagnosis codes used in RWE studies.MethodsA search in MEDLINE and Embase identified studies published from 2016 to 2023. Studies were included if they were conducted in US SCD populations and reported complications/comorbidities and respective International Classification of Diseases, Clinical Modification (ICD-CM) codes. All identified complications/comorbidities and codes were reviewed by a certified medical coding expert and hematologist.ResultsOf 1851 identified studies, 39 studies were included. The most reported complications/comorbidities were stroke, acute chest syndrome, pulmonary embolism, venous thromboembolism, and vaso-occlusive crisis. Most of the studies used ICD-9-CM codes (n = 21), while some studies used ICD-10-CM codes (n = 3) or both (n = 15), depending on the study period. Most codes reported in literature were heterogeneous across complications/comorbidities. The medical coding expert and hematologist recommended modifications for several conditions.ConclusionWhile many studies we identified did not report their codes and were excluded from this review, the studies with codes exhibited diverse coding definitions. By providing a standardized set of diagnosis codes that were reported by studies and reviewed by a coding expert and hematologist, our review can serve as a foundation for accurately identifying complications/comorbidities in future research, and may reduce heterogeneity, enhance transparency, and improve reproducibility. Future efforts focused on validating these code lists are needed.
引用
收藏
页数:28
相关论文
共 50 条
  • [11] Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature
    Brandow, Amanda M.
    Farley, Rebecca A.
    Panepinto, Julie A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (09) : 1501 - 1511
  • [12] Neurologic complications of sickle cell disease in Africa A systematic review and meta-analysis
    Noubiap, Jean Jacques
    Mengnjo, Michel K.
    Nicastro, Nicolas
    Kamtchum-Tatuene, Joseph
    NEUROLOGY, 2017, 89 (14) : 1516 - 1524
  • [13] Prevalence, Risk Factors, and Complications of Sickle Cell Disease in Saudi Arabia: A Systematic Review
    Hamed, Nazim F.
    Alatawi, Yousef Dakheel Allah
    AlKabbani, Danya Mohammed Zuhair
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [14] Stigma of Sickle Cell Disease: A Systematic Review
    Bulgin, Dominique
    Tanabe, Paula
    Jenerette, Coretta
    ISSUES IN MENTAL HEALTH NURSING, 2018, 39 (08) : 675 - 686
  • [15] A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
    Ahmar U. Zaidi
    Alexander K. Glaros
    Soyon Lee
    Taiji Wang
    Rhea Bhojwani
    Eric Morris
    Breanne Donohue
    Jincy Paulose
    Şerban R. Iorga
    Dave Nellesen
    Orphanet Journal of Rare Diseases, 16
  • [16] A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
    Zaidi, Ahmar U.
    Glaros, Alexander K.
    Lee, Soyon
    Wang, Taiji
    Bhojwani, Rhea
    Morris, Eric
    Donohue, Breanne
    Paulose, Jincy
    Iorga, Serban R.
    Nellesen, Dave
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [17] Evidence and Gaps in Clinical Outcomes of Voxelotor in Sickle Cell Disease: A Systematic Literature Review
    Yassin, Mohamed A.
    BLOOD, 2024, 144 : 5342 - 5343
  • [18] Burden of Illness of Sickle Cell Disease in Countries of the Middle East: A Systematic Literature Review
    Bailey, Miranda
    Gibbs, Megan
    Dani, Nidhi
    Mendell, Ari
    Thompson, Melissa
    BLOOD, 2019, 134
  • [19] Cardiac complications of sickle cell disease in pediatric patients: A case report and contemporary literature review
    Smerling, Jonathan
    Burns, Joseph
    Haimed, Abraham
    Ganigara, Madhusudan
    Appiah-Kubi, Abena O.
    Aygun, Banu
    Mitchell, Elizabeth C.
    Dhar, Arushi
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2022, 66
  • [20] Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature
    Charneski, Lisa
    Congdon, Heather Brennan
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (11) : 895 - 900